Group Post |
Why a Century-Old Vaccine Offers New Hope Against Pathogens |
FNUOvviyaa |
Group Post |
White House announces global COVID-19 summit in May |
FNUOvviyaa |
Group Post |
6 Months of U.S. Data Support Safety of mRNA COVID Vaccines |
FNUOvviyaa |
Group Post |
India steps up Covid surveillance after China surge |
FNUOvviyaa |
Group Post |
How Worrisome Are the Cases of Monkeypox in Kids? |
FNUOvviyaa |
Group Post |
Launch of WHO tool for benchmarking ethics oversight of health-related research involving human participants |
FNUOvviyaa |
Group Post |
EU regulator starts reviewing Spanish COVID vaccine booster |
FNUOvviyaa |
Group Post |
'We have arrived in the post-antibiotic era': WHO warns of too few new drugs for deadly superbugs |
FNUOvviyaa |
Group Post |
EU drops nearly all of its order for Valneva COVID vaccine |
FNUOvviyaa |
Group Post |
Fighting For Survival in the Shadow of Covid-19 |
FNUOvviyaa |
Group Post |
West Virginia surpasses 7,000 coronavirus deaths |
FNUOvviyaa |
Group Post |
Kenya: Severe drought fuels malnutrition, reduces hospital-delivery births in Turkana County |
FNUOvviyaa |
Group Post |
BioNTech expects Omicron-adapted vaccine deliveries as soon as October |
FNUOvviyaa |
Group Post |
WTO talks down to the wire with no major deals yet in sight |
FNUOvviyaa |
Group Post |
Spanish response to Covid poverty was too little, too late, report says |
FNUOvviyaa |
Group Post |
WHO renames lineages of monkeypox, moving away from geographic links |
FNUOvviyaa |
Group Post |
California delays coronavirus vaccine mandate for schools |
FNUOvviyaa |
Group Post |
Should you wait for the Omicron booster? Why experts say you should 'get it now!' |
FNUOvviyaa |
Group Post |
Vaccine makers prep bird flu shot for humans 'just in case'; rich nations lock in supplies |
FNUOvviyaa |
Group Post |
Ghana confirms first cases of deadly Marburg virus |
FNUOvviyaa |
Group Post |
Trials of new Covid vaccine raise hopes of once-a-year booster |
FNUOvviyaa |
Group Post |
China's COVID cases overwhelm hospitals |
FNUOvviyaa |
Group Post |
Axcella long COVID treatment helps some patients in small trial |
FNUOvviyaa |
Group Post |
UK scientists look to repurpose existing antiviral drugs for COVID |
FNUOvviyaa |
Group Post |
Second Booster Protects Against Breakthrough COVID-19 Variant Infections in Health Care Workers |
FNUOvviyaa |
Recent Comments